Scott Rocklage, started working for 5AM Ventures in 2003. He started off as a venture partner. A year later he rose to the position Managing Partner in the same organization. Dr. Rocklage has held various positions in his careers.
These include: Chairman and CEO of Cubist Pharmaceuticals, President of Nycomed Interventional President and CEO of Nycomed Salutar. Dr. Rocklage holds a B.S. in Chemistry from the “University of California, Berkeley,” and a Ph.D. in Chemistry from the “Massachusetts Institute of Technology.” Read more: Scott Racklage | Bloomberg and Scott Racklage | Crunchbase
Dr. Scott Rocklage has been an inspiration to many people in the field of biochemical research and entrepreneurship. Rocklage who is based in Boston has a vast knowledge of healthcare management, which is a field he has served for about 30 years.
This experience coupled with a background in scientific research and leadership roles makes him an effective leader in the field pharmaceuticals, health care, and venture capital.
From this vast educational and work experience, Dr. Rocklage has seen three drug applications approved by the FDA under his name. He has also been credited with entering 6 other candidates into clinical tests. He has directly or indirectly invented 30 Patents in the United States. Also under his name are over 100 publications.
5AM Company engages in the formation of companies. As the name 5am, it indicates formation at an early stage. Rocklage roles at 5AM involve maintaining the portfolio of the company and studying emerging facets of life science. He works closely with other entrepreneurs serving in the area of life science.
They will include people such as business executives, physicians, and scientists. With such people, they come up with new drugs that address issues in the field of medicine.
Dr. Scott Rocklage has steered 5AM Ventures to great achievements and has attracted clients from far and wide. Dr. Rocklage encourages the use of modern techniques in diagnosing and treating medical problems.